Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+50Malignant Bladder Neoplasm+23.3Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+16.7Malignant Pancreatic Neoplasm+16.7Malignant Vulvar Neoplasm+10Malignant Kidney Neoplasm+6.6Malignant Esophageal Neoplasm+3.4Malignant Anal Neoplasm+3.4Malignant Salivary Gland Neop…+3.3Malignant Testicular Neoplasm+3.3Malignant Vaginal Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Liver Neoplasm0Malignant Lung Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+50100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
40917
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
90
activityPercentile
40

ranking row 2603874

2▲2Malignant Bladder Neoplasm+23.396.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
16796
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
70
activityPercentile
46.7

ranking row 2603875

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8092
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2603876

4▲1Malignant Laryngeal Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3811
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
36.7
activityPercentile
20

ranking row 2603878

4▲2Malignant Pancreatic Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
45885
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
96.7
activityPercentile
80

ranking row 2603877

6▲2Malignant Vulvar Neoplasm+1083.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1347
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2603879

7▲3Malignant Kidney Neoplasm+6.680Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14021
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
63.3
activityPercentile
56.7

ranking row 2603880

8▲4Malignant Esophageal Neoplasm+3.476.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
15961
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2603881

9▲5Malignant Anal Neoplasm+3.473.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1370
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
26.7
activityPercentile
23.3

ranking row 2603882

10▲4Malignant Salivary Gland Neoplasm+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1085
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2603883

11▲3Malignant Testicular Neoplasm+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
458
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
10
activityPercentile
6.7

ranking row 2603884

11▲2Malignant Vaginal Neoplasm+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
431
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
3.3
activityPercentile
0

ranking row 2603885

13▼2Malignant Mesothelioma+3.360Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2442
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2603886

14=Malignant Liver Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
27958
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
83.3
activityPercentile
83.3

ranking row 2603888

14=Malignant Lung Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
139601
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2603887

14=Malignant Prostate Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
31636
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2603889

14=Malignant Rectal Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10979
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2603890

18▲14Malignant Thyroid Gland Neoplasm-3.343.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2047
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2603891

19▲5Malignant Hypopharyngeal Neoplasm-3.340Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
453
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
6.7
activityPercentile
10

ranking row 2603892

20▲2Malignant Breast Neoplasm-3.436.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
42747
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2603893

20▲3Malignant Central Nervous System Neoplasm-3.436.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
17232
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
73.3
activityPercentile
76.7

ranking row 2603894

22▲4Malignant Penile Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
319
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2603895

23▲3Leukemia-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23337
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2603896

23▲5Malignant Ovarian Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13445
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
60
activityPercentile
70

ranking row 2603897

23▲6Malignant Uterine Corpus Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6787
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
43.3
activityPercentile
53.3

ranking row 2603898

26▲4Malignant Gastric Neoplasm-13.416.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11092
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
53.3
activityPercentile
66.7

ranking row 2603899

27▲4Multiple Myeloma-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12455
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
56.7
activityPercentile
73.3

ranking row 2603900

27▲5Non-Hodgkin Lymphoma-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
20270
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
76.7
activityPercentile
93.3

ranking row 2603901

29▲5Malignant Cervical Neoplasm-206.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4152
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
40
activityPercentile
60

ranking row 2603902

30▲5Hodgkin Lymphoma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
943
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
16.7
activityPercentile
36.7

ranking row 2603903

31▲5Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
679
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2603904

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 232565d9173bda1706a3b9ed